NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Alon Ben-Noon$22.4M
Market Cap • 07/05/20242017
(há 7 anos)
2021
(3 years ago)
NASDAQ
Listagem
Herzliya
14
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NRSNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.